Related Experiment Video
Updated: Jun 29, 2025
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Pentafecta evaluation in robot-assisted radical prostatectomy by risk group
Víctor E Corona-Montes1,2,3,4, Juan E Sánchez-Núñez2, Rocío N Gómez-López1
1Departamento de Urología y Cirugía Robótica, Centro Médico A.B.C. (American British Cowdray) Observatorio.
Robot-assisted radical prostatectomy (RARP) achieved a 35.7% pentafecta rate in prostate cancer patients. Outcomes were similar across low, intermediate, and high-risk groups at 12 months.
Area of Science:
- Urology
- Oncology
- Robotic Surgery
Background:
- Radical prostatectomy is a key treatment for organ-confined prostate cancer.
- Advancements in robotic surgery are influencing patient outcomes.
Purpose of the Study:
- To evaluate the pentafecta rate in patients undergoing robot-assisted radical prostatectomy (RARP).
- To stratify RARP outcomes based on prostate cancer risk groups.
Main Methods:
- Retrospective, observational, descriptive study.
- Included 112 patients who underwent RARP between 2013 and 2020.
Main Results:
- Overall pentafecta rate at 12 months was 35.7%.
- Pentafecta rates by risk group at 1 year: 43% (low-risk), 26% (intermediate-risk), and 22% (high-risk).
Conclusions:
- RARP demonstrated functional and oncological results comparable to existing literature.
- Outcomes were consistent across different prostate cancer risk strata.
More Related Videos
06:08A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
12:45Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022